Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02906982 · ClinicalTrials.gov registry record · NA

Evaluating the Efficacy of a Gum Health Formulation on Teeth Whitening in Patients With Gingivitis and Periodontitis

A NA study of Periodontal Diseases and Tooth Discoloration, sponsored by Glo Science.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT02906982: Completed NA study of Periodontal Diseases and Tooth Discoloration, sponsored by Glo Science.

NCT02906982 is a NA study of Periodontal Diseases and Tooth Discoloration that has completed, run by Glo Science. The registered enrollment target is 30 participants, below the 160-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02906982, a NA study of Periodontal Diseases and Tooth Discoloration, has completed, sponsored by Glo Science.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the efficacy of a novel gum health formulation, when used in an intra-oral device or on a toothbrush, for teeth whitening and clinical improvements in periodontal diseases.

Primary Outcome

Tooth Shade Value was measured using a Vita Shade Guide and the measurement was transformed to a standardized value.

Interventions

  • OTHER Gum health formulation in intra-oral device
  • OTHER Gum health formulation on toothbrush

Study Locations (1)

New York

  • EEC Institute, Inc. - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2015-10
Est. Completion 2016-04
Phase NA
Glo Science

3 total trials

What the finished NCT02906982 record still lists

NCT02906982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 160-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (81% lower).

The record links to 2 conditions, with Periodontal Diseases appearing as the primary indexed condition, and to 2 interventions - of which Gum health formulation in intra-oral device is the first listed.

NCT02906982 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02906982 about?

NCT02906982 is a clinical study titled "Evaluating the Efficacy of a Gum Health Formulation on Teeth Whitening in Patients With Gingivitis and Periodontitis". The purpose of this study is to evaluate the efficacy of a novel gum health formulation, when used in an intra-oral device or on a toothbrush, for teeth whitening and clinical improvements in periodontal diseases.

What is the current status of trial NCT02906982?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2015-10. Estimated completion is 2016-04.

What conditions does trial NCT02906982 study?

This clinical trial studies the following conditions: Periodontal Diseases, Tooth Discoloration.

What interventions are being tested in trial NCT02906982?

The interventions under investigation include: Gum health formulation in intra-oral device (OTHER), Gum health formulation on toothbrush (OTHER).

Who is sponsoring clinical trial NCT02906982?

This trial is sponsored by Glo Science, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02906982 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Periodontal Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02906982's enrollment target sits among peer trials

30 11th of 15 higher than 5 of 15 other Periodontal Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Periodontal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02906982, the US trial registry maintained by the National Library of Medicine. NCT02906982 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.